These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9443109)

  • 1. Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay.
    Izopet J; Tamalet C; Pasquier C; Sandres K; Marchou B; Massip P; Puel J
    J Med Virol; 1998 Jan; 54(1):54-9. PubMed ID: 9443109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy.
    Debiaggi M; Zara F; Pistorio A; Bruno R; Sacchi P; Patruno SF; Achilli G; Romero E; Filice G
    Int J Infect Dis; 2000; 4(4):187-93. PubMed ID: 11231180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons.
    Bruisten SM; Reiss P; Loeliger AE; van Swieten P; Schuurman R; Boucher CA; Weverling GJ; Huisman JG
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1053-8. PubMed ID: 9718120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 induction-maintenance at the lymph node level: the "Apollo-97" Study.
    Lafeuillade A; Poggi C; Chadapaud S; Hittinger G; Chouraqui M; Delbeke E;
    J Acquir Immune Defic Syndr; 2001 Oct; 28(2):154-7. PubMed ID: 11588509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy.
    Tamalet C; Lafeuillade A; Fantini J; Poggi C; Yahi N
    AIDS; 1997 Jun; 11(7):895-901. PubMed ID: 9189215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy.
    Andreoni M; Parisi SG; Sarmati L; Nicastri E; Ercoli L; Mancino G; Sotgiu G; Mannazzu M; Trevenzoli M; Tridente G; Concia E; Aceti A
    AIDS; 2000 Jan; 14(1):23-9. PubMed ID: 10714564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay.
    Désiré N; Dehée A; Schneider V; Jacomet C; Goujon C; Girard PM; Rozenbaum W; Nicolas JC
    J Clin Microbiol; 2001 Apr; 39(4):1303-10. PubMed ID: 11283046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
    Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
    J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA.
    Lin HJ; Haywood M; Hollinger FB
    J Clin Microbiol; 1996 Feb; 34(2):329-33. PubMed ID: 8789009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy.
    Vitone F; Gibellini D; Schiavone P; Re MC
    J Clin Virol; 2005 Jul; 33(3):194-200. PubMed ID: 15911440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of HIV-1 viral RNA and proviral DNA by isotopic competitive PCR.
    Gratzl S; Moroni C; Hirsch HH
    J Virol Methods; 1997 Jul; 66(2):269-82. PubMed ID: 9255738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy.
    Izopet J; Salama G; Pasquier C; Sandres K; Marchou B; Massip P; Puel J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):478-83. PubMed ID: 9859961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
    Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
    Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.
    Debiaggi M; Zara F; Spinillo A; De Santolo A; Maserati R; Bruno R; Sacchi P; Achilli G; Pistorio A; Romero E; Filice G
    Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):91-6. PubMed ID: 11305478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of drug-related genotypic changes in HIV-1 from serum using the selective polymerase chain reaction.
    Anderson BD; Shirasaka T; Kojima E; Yarchoan R; Mitsuya H
    Antiviral Res; 1994 Dec; 25(3-4):245-58. PubMed ID: 7710271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral effect of zidovudine-didanosine combination on blood and lymph nodes.
    Lafeuillade A; Tamalet C; Poggi C; Pellegrino P; Tourres C; Izopet J
    AIDS; 1997 Jan; 11(1):67-72. PubMed ID: 9110077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease.
    Verhofstede C; Reniers S; Van Wanzeele F; Plum J
    AIDS; 1994 Oct; 8(10):1421-7. PubMed ID: 7529507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization.
    Dyrhol-Riise AM; Voltersvik P; Berg OG; Olofsson J; Kleivbo S; Asjö B
    AIDS Res Hum Retroviruses; 2001 May; 17(7):577-86. PubMed ID: 11375053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effect.
    Montoya JG; Wood R; Katzenstein D; Holodny M; Merigan TC
    J Clin Microbiol; 1993 Oct; 31(10):2692-6. PubMed ID: 7902845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.
    Havlir DV; Marschner IC; Hirsch MS; Collier AC; Tebas P; Bassett RL; Ioannidis JP; Holohan MK; Leavitt R; Boone G; Richman DD
    N Engl J Med; 1998 Oct; 339(18):1261-8. PubMed ID: 9791141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.